Paspigioni Heads to London for BioTrinity’s 20th Anniversary 🧬

The life sciences sector doesn’t stand still, and neither do we.

This April, the Paspigioni team is heading to London for BioTrinity 2026. As the conference celebrates its 20th anniversary, it remains one of the premier gatherings for the brightest minds in investment, regulation, and drug development.

Why BioTrinity matters in 2026

While digital networking has its place, nothing replaces the high-level strategic insights found in BioTrinity’s keynote sessions. This year’s lineup features industry titans like Steve Bates OBE and Tim Haines, offering a "boots on the ground" look at:

• Capital Market Trends: Navigating the current investment landscape.

• Regulatory Evolution: How shifting frameworks are impacting speed-to-market.

• The Next Decade of Innovation: Looking beyond the 20th-anniversary milestone.

Connecting with Paspigioni

At Paspigioni, we believe that the best breakthroughs happen at the intersection of collaboration and insight. We are attending BioTrinity to stay at the forefront of these industry shifts, ensuring that our internal strategies are informed by the most current data and expert perspectives available.

Are you attending BioTrinity 2026? We’d love to connect. Whether you’re interested in discussing the latest keynote takeaways or exploring how Paspigioni is navigating the 2026 biotech landscape, let’s grab a coffee in London.

• When: 14–15 April

• Where: London, UK

• Let's Meet: contact us